Furthermore, studies have shown that FD patients exhibit reduced 5‐HT3R activity and increased 5‐HT4R expression in their stomachs, further suggesting a pivotal role of altered 5‐HT signaling in FD pathogenesis and treatment [466, 467, 468]. This evidence concerns the gene HTR4 and Fabry disease.